Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
640 studies found for:    "chronic graft versus host disease"
Show Display Options
Rank Status Study
1 Terminated Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)
Condition: Chronic Graft Versus Host Disease
Intervention: Other: PET-CT Scan
2 Recruiting A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host-disease
Interventions: Procedure: Extracorporeal Photopheresis (ECP);   Drug: Interleukin-2
3 Unknown  Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
Condition: Steroid-Refractory Chronic GVHD
Intervention: Drug: Rituximab
4 Recruiting Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
Condition: Chronic Graft-Versus-Host Disease
Intervention: Biological: Mesenchymal Stromal Cells
5 Completed
Has Results
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Rituximab
6 Not yet recruiting Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
Condition: Chronic Graft-Versus-Host Disease
Intervention: Drug: Arsenic Trioxide Injectable Solution
7 Unknown  Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease
Condition: Chronic Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
8 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: Cyclosporine and Glucocorticoid
9 Not yet recruiting Multiple Donor Treg DLI for Severe Refractory Chronic GVHD
Condition: Chronic Graft Versus Host Disease
Intervention: Biological: T reg DLI
10 Active, not recruiting Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Condition: Chronic GVHD
Interventions: Drug: Sirolimus + calcineurin inhibitor + prednisone;   Drug: Sirolimus + prednisone
11 Recruiting Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Ofatumumab
12 Withdrawn Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host Disease
Condition: Active Chronic Graft Versus Host Disease
Intervention: Drug: Pentostatin; Cyclophosphamide; Rituximab
13 Terminated
Has Results
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Alefacept
14 Withdrawn A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
Condition: Chronic Graft-Versus-Host Disease
Interventions: Drug: LBH589;   Drug: Methylprednisolone
15 Active, not recruiting A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: ECP(Methoxsalen)+Corticosteroids+Cyclosporine or Tacrolimus;   Drug: Corticosteroids/Cyclosporine/Tacrolimus
16 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
17 Recruiting A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Graft vs Host Disease
Intervention: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease
18 Completed
Has Results
Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: bortezomib;   Drug: Prednisone
19 Unknown  Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Alemtuzumab and Rituximab combination
20 Unknown  Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Conditions: Chronic Graft-Versus-Host Disease;   Acute Graft-Versus-Host Disease;   Steroid Refractory Graft-Versus-Host Disease
Interventions: Drug: Rapamycin;   Other: T regulatory cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.